Table 2 Methods for fertility preservation in SLE patients receiving cyclophosphomide
From: Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus
Limiting cytotoxic agent exposure especially in women > age 30 |
GnRH agonists during cyclophosphamide therapy |
Cryopreservation of oocytes or embryos (time delay is problematic as there is usually an urgent need for treatment) |
Ovarian tissue cryopreservation (research technique only at this time) |